(19)
(11) EP 1 381 360 A1

(12)

(43) Date of publication:
21.01.2004 Bulletin 2004/04

(21) Application number: 02723701.5

(22) Date of filing: 28.03.2002
(51) International Patent Classification (IPC)7A61K 31/41
(86) International application number:
PCT/US2002/009954
(87) International publication number:
WO 2002/078697 (10.10.2002 Gazette 2002/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.03.2001 US 279563 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • MARINO, Joseph, P., Jr.
    King of Prussia, PA 19406 (US)
  • THOMPSON, Scott, K.
    King of Prussia, PA 19406 (US)
  • VEBER, Daniel, F.
    Ambler, PA 19002 (US)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) COMPOUNDS AND METHODS FOR INHIBITING METAP2 IN MAMMALS